Insights (Filter: pharmaceutical industry)
-
The Relevance of Intellectual Property for Pharmaceutical Innovation
By: Guest AuthorBy Mr Maarten Meulenbelt, Sidley Austin LLP* In the pharmaceutical industry, the role of Intellectual Property (IP) as an incentive for product...
-
Compulsory Licensing of IP-protected Drugs: Colombia’s Panacea for Access to Better Healthcare Services?
By: Matthias BauerOn 30 May 2018, Colombia joined the OECD as the group’s 37th member. Prior to the country’s accession, the Colombian government implemented a...
-
The European Commission’s Pharmaceutical Innovation Incentives Review Is at Risk of Serious Overreach
By: Guest AuthorPhilip Stevens is executive director of Geneva Network, a UK-based research organisation working on international innovation and trade...